First Time Loading...

Aridis Pharmaceuticals Inc
NASDAQ:ARDS

Watchlist Manager
Aridis Pharmaceuticals Inc Logo
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Watchlist
Price: 0.0597 USD 4.01%
Updated: May 20, 2024

Aridis Pharmaceuticals Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aridis Pharmaceuticals Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Retained Earnings
-$195.7m
CAGR 3-Years
-25%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$2.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
$10.7B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$27.9B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-15%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
$11.2B
CAGR 3-Years
95%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$28B
CAGR 3-Years
33%
CAGR 5-Years
37%
CAGR 10-Years
N/A

See Also

What is Aridis Pharmaceuticals Inc's Retained Earnings?
Retained Earnings
-195.7m USD

Based on the financial report for Dec 31, 2022, Aridis Pharmaceuticals Inc's Retained Earnings amounts to -195.7m USD.

What is Aridis Pharmaceuticals Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-33%

Over the last year, the Retained Earnings growth was -18%. The average annual Retained Earnings growth rates for Aridis Pharmaceuticals Inc have been -25% over the past three years , -33% over the past five years .